Principles of pharmacologic treatment for hyperlipoproteinemia
Kłosiewicz-Latoszek, L.
Wiadomosci Lekarskie 43(15-16): 821-833
1990
ISSN/ISBN: 0043-5147 PMID: 2275203 Document Number: 359002
Document emailed within 1 workday
Related Documents
Enck, P.; Frieling, T.; Lübke, H.J.; Strohmeyer, G. 1993: Treatment of fecal incontinence. Morphologic and pharmacologic principles Der Internist 34(1): 51-58Pindur, G.; Köhler, M.; Heiden, M.; Leipnitz, C.; Rupp, K.H.; Wenzel, E. 1990: Pharmacologic and clinical principles for rational anti-thrombotic preventive treatment with low molecular weight heparin Langenbecks Archiv für Chirurgie. Supplement Ii Verhandlungen der Deutschen Gesellschaft für Chirurgie. Deutsche Gesellschaft für Chirurgie. Kongress 1990: 1149-1155
Chibisov, I.V.; Karmanskiĭ, I.M. 1982: Hyperlipoproteinemia in glycogenosis and its treatment Pediatriia 2: 6-9
Widhalm, K. 1990: Dietary treatment of hyperlipoproteinemia Wiener Medizinische Wochenschrift 140(4): 88-93
1983: Pathogenesis, diagnosis and therapy of ulcer diseases. 6. Therapy. Pharmacologic principles and antacid therapy Die Medizinische Welt 34(47): 14-18
Razboinikov, S.; Shipkov, T. 1973: Clinical experience in the treatment of hyperlipoproteinemia Vutreshni Bolesti 12(5): 114-121
Ciświcka-Sznajderman, M. 1976: Pharmacological treatment of primary hyperlipoproteinemia Polski Tygodnik Lekarski 31(7): 289-291
Bartz, V.T.; Gatz, J.; Slotty, C.; Schröter, C.; Töle, R.; Wand, P. 1993: Long-term treatment of hyperlipoproteinemia with etofibrate Fortschritte der Medizin 111(25): 398-400
Kleiber, G.; Leickert, K.H. 1979: Beta-pyridyl-carbinol in the treatment of hyperlipoproteinemia Zfa. Zeitschrift für Allgemeinmedizin 55(21): 1199-1205
Mincou, I.; Străchinariu, R.; Georgesco, M. 1979: Specific treatment of primary hyperlipoproteinemia in diabetes mellitus Medecine Interne 17(2): 163-168
Válek, J.; Jirkovská, A.; Grafnetter, D. 1991: Small doses of the resin Colestid in the treatment of hyperlipoproteinemia Casopis Lekaru Ceskych 130(6): 172-176
Costa, F.V. 1988: Clinical pharmacologic aspects of mepartricin. Possible pharmacologic interference with digitaloids and anticoagulants Minerva Urologica e Nefrologica 40(2 Suppl): 5-6
Sleptsova, S.I. 1987: Effects of various pharmacologic and non-pharmacologic agents on the mother and fetus (data for the health promotion propaganda) Akusherstvo i Ginekologiia 12: 68-71
Manojlović, D.; Lepsanović, L.; Micić, D.; Sumarac, M.; Kendereski, L.; Popović, V.; Mićić, J. 1991: Multicenter study of the efficacy and tolerance of gemfibrozil and fenofibrate in the treatment of primary hyperlipoproteinemia Srpski Arhiv Za Celokupno Lekarstvo 119(1-2): 22-25
Ivanova, I.L.; Ian'kova, V.I.; Knyshova, V.V.; Kozlovskaia, E.P. 2000: A specialized product with antioxidant action in the treatment of lipid disorders in experimental hyperlipoproteinemia Voprosy Pitaniia 69(1-2): 13-15
Weisweiler, P. 1985: Dietary treatment of hyperlipoproteinemia. Reduction of atherogenic lipid fractions in normal subjects Fortschritte der Medizin 103(7): 148-150
Falko, J.M.; Witztum, J.L.; Schonfeld, G.; Bateman, J. 1979: Dietary treatment of type V hyperlipoproteinemia fails to normalize low levels of high-density lipoprotein cholesterol Annals of Internal Medicine 91(5): 750-751
Kwiterovich, P.O.; Bachorik, P.S.; Franklin, F.A.; Margolis, S.; Georgopoulos, L.; Teng, B.; Sniderman, A.D. 1985: Effect of dietary treatment on the plasma levels of lipids, lipoprotein cholesterol and LDL B protein in children with type Ii hyperlipoproteinemia Progress in Clinical and Biological Research 188: 123-137
Honorato Pérez, J.; Azanza Perea, J.R.; Cuena Boy, R. 1984: Pharmacologic treatment of ulcers Revista de Medicina de la Universidad de Navarra 28(2): 53-58
Pinals, R.S. 1992: Pharmacologic treatment of osteoarthritis Clinical Therapeutics 14(3): 336-46; Discussion 335